United States: February 2015 Corporate Alert

The Herrick Advantage

On March 13th, Herrick partners Irwin A. Kishner, John R. Goldman and Daniel A. Etna will speak at the Benjamin N. Cardozo School of Law's 3rd Annual Sports Law Symposium. The event attracts high-profile guests from the NBA, MLB, NHL, NFL and MLS. Several panels will focus on the current issues impacting sports and law. For more information, please click here.


Delaware Chancery Court Awards $194 Million in Expectation Damages

The Delaware Chancery Court awarded PharmAthene, Inc., a pharmaceutical company, $194 million on its claim against SIGA Technologies, Inc., another pharmaceutical company, for failure to negotiate a drug license in good faith.  PharmAthene and SIGA executed a merger agreement which contained a provision that if the merger fell through, the parties would negotiate a drug license in good faith pursuant to the term sheet attached to the merger agreement.  SIGA subsequently terminated the merger agreement and, although the parties began negotiating the drug license, by that time, SIGA's overall financial position and business outlook had dramatically improved.  SIGA proposed license terms materially different from those contained in the term sheet.  In response, PharmAthene sued SIGA.

The Delaware Supreme Court held that SIGA had breached the covenant to negotiate in good faith by demanding terms that were not "substantially similar" to those contained in the term sheet. The Chancery Court initially awarded PharmAthene expectation damages. The Supreme Court found PharmAthene's evidence of expectation damages to be too speculative and remanded the case back to the Chancery Court for reconsideration.  In remanding the case, the Supreme Court ruled that expectation damages may be awarded only for losses that can be proven with reasonable certainty.

On remand, the Chancery Court awarded PharmAthene $194 million, such amount representing the present value of expected future profits from sales of the drug at issue.  In awarding expectancy damages to PharmAthene, the Chancery Court relied in part upon new evidence introduced since the commencement of the lawsuit that SIGA had entered into a contract to sell the drug at issue to the federal government.

The prior court proceedings in this case were reported in the November 2011 and June 2013 Corporate Alerts.

PharmAthene v. SIGA Technologies, Inc., C. A. No. 2627 - VCP (Del. Ch. Ct. Jan. 15, 2015)

Delaware Chancery Court Rules Interested Directors Are Not Controlling Stockholders

The Delaware Chancery Court ruled that the business judgment standard of review, rather than the heightened entire fairness standard, applied to a sale of assets transaction.  Under the transaction at issue, the company purchased assets from an entity controlled by two directors of the company.  The transaction, however, was approved by the company's audit committee consisting of the company's three other directors.

The claimants unsuccessfully argued that the heightened standard of review should apply because the two interested directors should be treated as controlling stockholders.  The interested directors owned less than 50% of the company's common stock.  The court, relying on two of its recent opinions, ruled that minority stockholders (such as the interested directors) should be viewed as controllers only in situations where they exercise actual control over the board of directors.  The court found no evidence was presented that the interested directors exerted actual control over the board of directors in connection with the asset sale.

In re Sanchez Energy Derivative Litig., No. 9132 - VCG (Del. Ch. Ct. Nov. 11, 2014)

Delaware Chancery Court Refuses to Apply Implied Covenant of Good Faith and Fair Dealing

The Delaware Chancery Court dismissed a breach of contract claim which arose under a patent purchase agreement.  The purchase of the patents was conditioned upon receipt of approval by an Israeli governmental agency.  Under the patent purchase agreement, such approval was to be on terms "satisfactory in the sole discretion (which for purposes of this condition shall not, to the extent permitted by law, be subject to the implied covenant of good faith and fair dealing)" of the purchaser.  The court held that, under the agreement, whether the terms of the approval were satisfactory to Networks was "a decision that is unreviewable in the sense that, if it is timely taken, the defendant could then ... terminate." 

The seller under the patent purchase agreement argued unsuccessfully that the purchaser's exercise of its sole discretion was qualified by either (i) a "commercially reasonable efforts" standard contained in another provision of the agreement or (ii) a default good faith standard that could not be contracted away.  In ruling in favor of the purchaser, the court found as to the first argument that it was unreasonable to assume that the disclaimer of the implied covenant of good faith and fair dealing would result in the application of the higher "commercially reasonable efforts" standard.  With respect to the second argument, the court ruled that the provision's "language ... could not be any clearer," and that it was, in fact, "as clear as it gets."

Orckit Communications Ltd. v. Networks Inc. et al., C.A. No. 9658 (Del. Ch. Ct. Jan. 28, 2015)

Delaware Chancery Court Rules $112 Million Termination Fee Conditions Not Satisfied

The Delaware Chancery Court ruled that a target company was barred from seeking the $112 million reverse termination fee provided for in the merger agreement.  The court found that the target company had failed to satisfy all of the conditions to closing the merger.  After entering into the merger agreement, the target company experienced labor difficulties with both its Chinese and domestic labor unions. The foreign labor union dispute resulted in the cessation of operations for a significant period of time.  The domestic labor union claimed that the merger would require renegotiation of the collective bargaining agreement.  The acquirer sought to negotiate a new collective bargaining agreement with the domestic labor union, but failed to reach agreement.

The target company, alleging that the acquirer had failed to negotiate a new collective bargaining agreement in good faith, claimed that it was entitled to the $112 million reverse termination fee.  In response, the acquirer claimed that the target company was not entitled to such fee by reason of the target company not having satisfied all of the conditions to closing the merger.  In particular, the acquirer claimed that the target company breached a merger agreement covenant requiring the continued operation of each subsidiary of the target company in the ordinary course of business.  The target company argued that the covenant applied only to operations within its control.  

The court, in ruling in favor of the acquirer, held that the labor disputes prevented the target company from satisfying its merger closing conditions.  In so ruling, the court stated that "ordinary course" means "the normal and ordinary routine of conducting business," and that the labor disputes prevented compliance with the covenant at issue.

Cooper Tire & Rubber Company v. Apollo (Mauritius) Holdings Pvt. Ltd, C. A. No. 8980-VCG (Del. Ch. Ct. Oct. 31, 2014)

SEC Proposes Dodd-Frank Disclosure Rule for Company Hedging Policies

On February 9, 2015, the Securities and Exchange Commission issued proposed rules to enhance corporate disclosure of company hedging policies for directors, officers and other employees under the Dodd-Frank Wall Street Reform and Consumer Protection Act.  Under the proposed rules, companies would be required to disclose in their annual meeting proxy statements whether directors, officers and other employees are permitted to purchase financial instruments designed to hedge or offset any decrease in the market value of their equity securities.  The proposed rule requires only disclosure of such hedging activities.  The proposed rule does not require companies to prohibit hedging transactions or to adopt policies that address hedging activities.  According to the Securities and Exchange Commission, the purpose of the proposed rules is to provide transparency to shareholders about whether the directors, officers and employees of the issuer are permitted to engage in transactions that mitigate or avoid the incentive alignment associated with their equity ownership. 

Securities Act Rel. No. 33-9723 (Feb. 9, 2015)

U.S. Ninth Circuit Court of Appeals Addresses Impact of Dodd-Frank Act upon Bank's Trust Preferred Securities

The U.S. Ninth Circuit Court of Appeals upheld the dismissal of a breach of contract claim involving a trust indenture for a bank's trust preferred securities.  The claim arose out of the redemption of the trust preferred securities.  The indenture permitted the issuer to redeem the trust preferred securities upon the occurrence of a "Capital Treatment Event." Under the indenture, a "Capital Treatment Event" is the reasonable determination by the issuer that, as a result of the occurrence of any change (including any prospective change) in law, there is more than an insubstantial risk that the issuer will not be entitled to treat the trust preferred securities as "tier 1 capital" for purposes of the capital adequacy guidelines of the Federal Reserve.  The issuer redeemed the trust preferred securities in response to the passage of the Dodd-Frank Wall Street Reform and Consumer Protection Act in July 2010.  This Act changes the law relating to trust preferred securities.  Under the Act, bank holding companies, such as the issuer, would no longer be permitted to use trust preferred securities as tier 1 capital beginning in 2013.  The trustee unsuccessfully argued that the issuer breached the indenture by redeeming the trust preferred securities in advance of the effective date of the Act's trust preferred securities provision.  The court, relying on the express language of the indenture, focused upon the inclusion of prospective changes in law within the definition of Capital Treatment Event.      

Turkle Trust v. Wells Fargo & Company, D.C. No. 4:11-cv-06494-CW (U.S. Ct. of Appeals (9th Cir.) Feb. 10, 2015)

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Emails

From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.